Abstract
Since 1975 we have used thiazides for prevention of renal calcium stones. Our experience1 confirms that of Yendt and Cohanim2 that in most cases stone formation will virtually cease during several years of follow-up and that subjective side effects in general are mild.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Ljunghall, U. Backman, B. G. Danielson, B. Fellström, G. Johansson, and B. Wikström, Scand. J. Urol. Nephrol. Suppl. 54 (1980).
E. R. Yendt, and M. Cohanim, Kid. Int. 13:197 (1978).
G. Johansson, Scand. J. Urol. Nephrol. Suppl. 51 (1979).
S. Ljunghall, Scand. J. Urol. Nephrol. Suppl. 54 (1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ljunghall, S., Backman, U., Danielson, B.G., Fellström, B., Johansson, G., Wikström, B. (1981). Long-term Treatment with Bendroflumethiazide for Prevention of Stones. Metabolic Effects. In: Smith, L.H., Robertson, W.G., Finlayson, B. (eds) Urolithiasis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8977-4_40
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8977-4_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8979-8
Online ISBN: 978-1-4684-8977-4
eBook Packages: Springer Book Archive